ScienceDaily Health

Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but experts warn the popular vitamin may do more harm than good. While biotin is often marketed for stronger hair and nails, there’s little evidence it actually helps cancer-related hair loss—and it can dangerously interfere with lab tests. Doctors say the supplement can distort key blood markers, potentially masking cancer recurrence or delaying treatment decisions.

A little-known tree from Brazil’s Atlantic Forest may hold a surprising weapon against COVID-19. Researchers discovered that compounds called galloylquinic acids, extracted from its leaves, can attack SARS-CoV-2 on multiple fronts—blocking the virus from entering cells, disrupting its replication, and even dampening harmful inflammation. Unlike many antivirals that target just one part of the virus, these natural compounds act in several ways at once, potentially making it harder for resistance to develop.

Eating eggs might do more than just start your day—it could help protect your brain. Researchers found that people 65 and older who eat eggs regularly have a significantly lower risk of developing Alzheimer’s disease, with daily or near-daily consumption linked to up to a 27% reduction. Even modest egg intake showed benefits, suggesting that small dietary changes could make a meaningful difference over time.

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a powerful metabolic enhancer directly into target cells. In mice, it outperformed existing treatments—curbing appetite, increasing weight loss, and improving blood sugar levels. Because the extra drug acts only where it’s needed, it can be used at much lower doses, potentially reducing side effects.

Some people taking Ozempic-like diabetes drugs may be getting dramatically better results for a surprising reason: why they overeat in the first place. A year-long study in Japan found that people who tend to eat because tempting food looks or smells irresistible were much more likely to lose weight and improve blood sugar levels on GLP-1 medications. But people who eat mainly in response to stress, sadness, or emotional struggles didn’t see the same long-term benefits.

Aging doesn’t just add fat—it redistributes it in risky ways, pushing more into the abdomen where it can harm health. Scientists found that testosterone plays a key role in this shift. In older women recovering from hip fractures, a testosterone gel combined with exercise helped prevent the usual rise in dangerous visceral fat. The result could point to a powerful new strategy for improving recovery and long-term health.

A new twin study suggests your genes may play a bigger role in your future success than your upbringing. Researchers found that IQ, which is largely genetically influenced, strongly predicts education, career, and income. Even twins raised in the same household diverged based on genetic differences. The findings hint that life outcomes may be more hardwired than many people expect.

Scientists in Sweden have taken a major step toward a potential cure for type 1 diabetes by developing a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice.

MIT neuroscientists have uncovered a surprising secret hidden in the adult brain: millions of “silent synapses,” dormant connections that lie in wait until new learning calls them into action. Once thought to exist only in early development, these inactive links make up about 30% of synapses in the adult cortex and can be rapidly activated to form fresh memories.

A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal cancer. Patients in a UK-led trial who received just nine weeks of pembrolizumab prior to surgery have remained cancer-free nearly three years later—an outcome that challenges the standard approach of surgery followed by months of chemotherapy.

A major 10-year clinical trial is turning one of the world’s most common knee surgeries on its head. Researchers found that trimming a damaged meniscus—a procedure long believed to relieve pain—offers no real benefit over placebo surgery. Even more surprising, patients who had the operation actually fared worse over time, with more symptoms, poorer function, faster progression of osteoarthritis, and a greater likelihood of needing additional surgery.

A chaotic sleep schedule in your 40s might be quietly setting the stage for heart trouble later. Researchers tracking thousands of people for over a decade found that those with highly inconsistent bedtimes—especially when they slept less than eight hours—faced about double the risk of serious cardiovascular events like heart attacks or strokes. Interestingly, it wasn’t when people woke up that mattered most, but how erratic their bedtime was.

Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue from within, reducing inflammation and jumpstarting healing. In animal studies, it successfully treated heart attack damage and even showed promise for conditions like traumatic brain injury and pulmonary hypertension. Unlike earlier approaches that required direct injection into the heart, this new therapy can be delivered intravenously, allowing it to spread evenly and act quickly.

GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using these medications may actually face more judgment than those who lose weight through diet and exercise—or even those who don’t lose weight at all. The stigma seems rooted in a perception that these drugs are an “easy way out,” creating a double bind where individuals are judged both for their weight and for how they choose to manage it.

A new study suggests travel could be a surprisingly powerful anti-aging tool. By viewing tourism through the lens of entropy, researchers found that positive travel experiences may help the body stay balanced and resilient. Activities like exploring new places, staying active, and connecting with others can boost immunity, metabolism, and stress recovery. However, stressful or unsafe travel could reverse these benefits.

A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of toxic amyloid proteins in the brain, a hallmark of the disease. In animal models, oral arginine not only lowered harmful protein deposits but also improved behavior and reduced brain inflammation.

For decades, relaxor ferroelectrics have powered everything from medical ultrasounds to sonar systems, yet their inner atomic structure remained a mystery—until now. Researchers have finally mapped their three-dimensional structure in unprecedented detail, uncovering hidden patterns in how electric charges are arranged at the nanoscale. The breakthrough not only challenges long-standing assumptions about how these materials behave but also allows scientists to refine the models used to design them.

Creatine might be famous in the gym, but its real story is far more interesting. Naturally produced in the body, it helps power cells by rapidly regenerating ATP—the fuel that keeps muscles, the brain, and even the heart running during intense activity. Supplementing with creatine can boost short bursts of physical performance and may even support memory, mood, and cognitive speed, especially in people with lower baseline levels.

A new study suggests depression may soon be detectable through a simple blood test—by tracking how certain immune cells age. Researchers found that accelerated aging in monocytes, a type of white blood cell, is closely tied to the emotional and cognitive symptoms of depression, like hopelessness and loss of pleasure, rather than physical symptoms such as fatigue.

GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a decade, researchers found that these medications were linked to significantly fewer psychiatric hospital visits and sick days.